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INTRODUCTION
Behc ,et’s disease (BD) is a chronic inflammatory disorder
involvingmultiple organs such as oral ulcerations, genital ulcer-
ations, uveitis, and skin lesions. It may also involve other organs,
including joints, heart, lungs, central nervous system, and
gastrointestinal tract. Although the main pathology of BD has
been known to be the underlying vasculitis, the exact etiopatho-
genesis is still unknown. Patients with BD have clustered in
the ethnic area adjacent to the ancient Silk Road that extends
from the eastern Asia to the Mediterranean basin (1, 2). Some
clinical features of this disease, including the prevalence of
HLA-B51, ileocecal ulcerations, and a positive pathergy reac-
tion, as well as a sexual predisposition to the disease, have been
described to be different according to the geographical areas (2,
3). Moreover, regional differences in the prevalence of the disease
within a country have been reported from Japan, which could
be due to the ethnic or geographic factors (4).
In Korea, information for the clinical features of BD in a
confined geographical region has been limited. Therefore, this
study was undertaken to evaluate the clinical characteristics of
a cohort of BD followed-up in a university medical center at
Yongdong districts (eastern coastal region of Kangwon Pro-
vince, Korea), and to compare the results with those of the
literature.
MATERIALS AND METHODS
During period from January 1997 thru July 2001, 73 pa-
tients with BD who satisfied the criteria by International
Study Group (ISG) (5) were prospectively analyzed. The demo-
graphic features of patients were as follows: 25 male and 48
female patients; mean age at onset (±SD), 35.2±8.9 yr; mean
age at presentation (±SD), 39.5±10.2 yr; mean duration of
Behc ,et’s disease, 5.6 yr (range 6 months to 40 yr); mean period
of the follow-up, 18.2 months (range 3 months to 54 months).
The age at onset was defined as the first time the patient
fulfilled the ISG criteria. The presence, absence, and character-
istics of each clinical manifestation were assessed by a rheuma-
tologist. The patients were evaluated by an ophthalmologist,
initially and whenever the ocular symptoms or signs were
encountered, and by specialists of related symptoms whenever
clinically indicated along the course of the disease. The inflam-
matory arthritis was defined as the presence of any episode of
either swelling, redness, or heating of the involved joints that
was confirmed by a rheumatologist.
The pathergy reaction was performed as described elsewhere
in all patients with BD (6). Briefly, intradermal prick with a
21-gauge disposable needle was done under sterile condition,
and the results were read at 48 hr by the same physician. The
formation of a papule or pustule was considered a positive
reaction. In addition, it was retested in a few BD patients with
initially negative reaction whose the disease flared up during
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The Clinical Features of Behc ,et’ s Disease in Yongdong Districts: 
Analysis of a Cohort Followed from 1997 to 2001
This study was undertaken to evaluate the clinical features of a cohort of Behc ,et’s
disease (BD) followed up from January 1997 to July 2001 in Yongdong districts in
Korea, and to compare the results with the literature. Overall features of clinical mani-
festations were similar to those described in the literature. However, the frequency
of gastrointestinal (GI) ulcerations was much higher than those of other Korean stud-
ies. The Korean studies including ours revealed a lower frequency of vascular lesions
and epididymitis compared with studies of other countries. The most common site
and pattern of inflammatory arthritis were knees and monoarticular involvement,
respectively. In addition, in most patients, the ocular lesions involved the posterior
uveal tract, and the terminal ileum and cecum were the most common sites of GI
involvement. Patients with ocular lesions or GI lesions showed a good prognosis
during the follow-up. The HLA-B51 antigen was positive in 50.7% of patients, and
it was more commonly found in patients with a familial BD.
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Accepted : 22 August 2002the follow-up. If the results were positive, they were also con-
sidered to have a positive reaction. In addition, HLA-B51 was
tested by a two-step polymerase chain reaction with sequence-
specific primers in all patients with BD (7, 8).
The data were entered onto a computer database, and ana-
lyzed by the SPSS statistical package program version 10.0
for Windows (SPSS Inc., Chicago, IL, U.S.A.). The statisti-
cal significance was evaluated by Fisher’s exact test. A p-value
less than 0.05 was considered to be statistically significant.
RESULTS
There was a female predominance, with a male-to-female
ratio of 1:1.92. The mean ages at onset in male and female
patients were 34.2±9.1 yr and 35.8±8.9 yr, respectively,
indicating no gender difference. The disease was most com-
monly in the thirties (41.1%), followed by twenties (30.1%)
and forties (20.5%). There were no patients under the age of
20 or over the age of 60 yr (Table 1).
The prevalence of clinical features in patients with BD is
presented in Table 2. Oral ulcerations were found in 100% of
patients, genital ulcerations in 75.3%, papulopustular eruption
or pseudofolliculitis in 57.5%, erythema nodosum-like lesions
in 52.1%, positive pathergy reaction in 34.2%, peripheral
arthritis in 24.7%, ocular lesions in 23.3%, gastrointestinal
ulcerations in 15.1%, vascular lesions in 5.5%, central nervous
system lesions in 4.1%, epididymitis in 1.4%, and pulmonary
involvement in 1.4%.
Recurrent oral ulcerations were the initial manifestation of
the disease in 63 patients (86.3%), followed by genital ulcer-
ations in 4 patients (5.5%), skin lesions in 3 patients (4.1%),
ocular lesions in 2 patients (2.7%), and arthritis in 1 patient
(1.4%). The sites of genital ulcerations in 56 patients are
depicted in Table 3. The vulva was the most common site for
female patients and scrotum for male patients. In addition,
the prevalence of skin lesions was different according to the
gender (Table 4). The more common skin lesions in male and
female patients were papulopustular eruption or pseudofol-
liculitis and erythema nodosum-like lesions, respectively.
The characteristics of inflammatory arthritis are depicted in
Table 5. The most common site of this lesion was the knees
followed by ankles and wrists. In 18 patients with inflamma-
tory arthritis, the mean frequency of arthritis attack was 2.4
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below 20 0
20-29 22 (30.1)
30-39 30 (41.1)
40-49 15 (20.5)
50-59 6 (8.2)
over 60 0
Age (yr)   No. of patients (%)
Table 1. The analysis of the age at disease onset 
Oral ulcerations 73 (100)
Genital ulcerations 55 (75.3)
Erythema nodosum-like lesion 38 (52.1)
*PPL/pseudofolliculitis 42 (57.5)
Positive pathergy reaction 25 (34.2)
Peripheral arthritis 18 (24.7)
Ocular lesions 17 (23.3)
Gastrointestinal lesions 11 (15.1)
Vascular lesions 4 (5.5)
Central nervous system lesions 3 (4.1)
Epididymitis 1 (1.4)
Pulmonary involvemet 1 (1.4)
*PPL: papulopustular lesions.
Clinical features   No. of patients (%)
Table 2. The prevalence of clinical features
Female Vulva 38 (69.1)
Vagina 7 (12.7)
Perineum 3 (5.4)
Cervix 1 (1.8)
Male Scrotum 14 (25.5)
Penis 5 (9.1)
Site   No. of patients (%)
Table 3. The sites of genital ulcerations in 55 patients
*EN-like lesions M 9 (23.7)
F 29 (76.3)
� PPL/Pseudofolliculitis M 20 (47.6)
F 22 (52.4)
*EN: erythema nodosum, 
� PPL: papulopustular lesions.
Sex   No. of patients (%)
Table 4. The prevalence of skin lesions according to gender
A. Site of inflammatory arthritis
Knee 9
Ankle 6
Wrist 6
Elbow 3
Metacarpophalangeal joint 3
Metatarsophalangeal joint 3
Proximal interphalangeal joint of hand 2
Shoulder 2
B. Other findings of inflammatory synovitis
Total frequency of arthritis 43
Mean frequency per patient 2.4
No. of patients with monoarthritis 30 (69.8%)
No. of patients with oligoarthritis 10 (23.3%)
No. of patients with polyarthritis 3 (7.0%)
No. of patients with asymmetric involvement 34 (79.1%)
No. of patients with symmetric involvement 9 (20.9%)
Inflammatory arthritis No. of patientss
Table 5. The characteristics of inflammatory arthritis in 18 patientsduring the follow-up. The most common pattern of arthritis
was monoarticular and asymmetric involvement. Radiographic
sacroiliitis was found in 5 patients (6.8%), in whom 3 patients
(4.1%) concurrently fulfilled the criteria of spondyloarthropathy
by the European Spondyloarthropathy Study Group (ESSG)
(9) as well as the ISG criteria. The enthesitis was observed
in 5 patients (6.8%), in whom 3 patients also met the ESSG
criteria (10). In addition, there were 2 patients with osteonecro-
sis or bone infarction, in whom one patient developed bone
infarction without the use of corticosteroids and the other had
a past history of significant corticosteroids administration to
treat the serious complications of BD (11).
The patterns of ocular involvement in 17 patients are pre-
sented in Table 6. In most patients, the posterior uveal track
was involved except 4 patients, of whom 3 had only an ante-
rior uveitis and one patient with a nodular scleritis, described
previously (12). The frequency of ocular involvement in male
and female patients was 28.0% and 20.8%, respectively, indi-
cating no gender difference (p=0.492). In addition, there have
been no patients who lost their vision from the ocular lesions
of BD during the follow-up with the exception of one patient
who had already lost his vision of left eye at presentation.
Table 7 shows the sites of gastrointestinal ulcerations in 11
patients. The terminal ileum or cecum was more commonly
involved. Four of these patients had undergone the surgical
procedures due to the bleeding or perforation from the intesti-
nal ulceration at presentation. However, no patients received
the surgical treatment during the follow-up period. In addi-
tion, three (27.3%) of patients with intestinal ulcerations had
a past history of erroneous diagnosis with an appendectomy.
As for the pathergy reaction, the male patients showed a
higher positive rate (44.0%) than the female patients (29.2%),
however, there was no statistical significance (p=0.299)
(Table 8).
The HLA-B51 antigen was positive in 37 (50.7%) of 73
patients. In addition, there were 3 families in which 8 patients
(11.0%) were affected by BD, and this antigen was positive
in 7 (87.5%) of these patients.
DISCUSSION
The comparative data of clinical features of BD in Korea,
Turkey, Germany, and Greece are presented in Table 9 (3,
13-17). Because the criteria for the clinical studies of BD in
Korea have not been unified, it is difficult to compare our data
with others in the literature. Whereas we employed the ISG
criteria, other authors adopted the criteria by the Behc ,et’s
Disease Research Committee of Japan (Japanese criteria) (18,
19) in which some authors comprised incomplete type and
others suspected type or possible type. The Korean studies
including ours showed the female predominance of patients,
and this was also the case in Japan and the United States.
However, males were more frequently affected in Germany,
Greece, and the Middle Eastern countries (2, 3). Whereas the
age at onset in the current study and in a multicenter study
in Korea (13) was older when compared with that in other
countries, another study in Korea (15) showed an earlier onset
which might be partly due to the criteria adopted to embrace
the possible type. In addition, the prevalence of vascular
involvement and epididymitis in Korean studies including
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Anterior and posterior uveitis 8 (47.1)
Posterior uveitis 3 (17.6)
Anterior uveitis 3 (17.6)
Posterior uveitis and retinal vasculitis 2 (11.8)
Scleritis 1 (1.4)
Pattern   No. of patients (%)
Table 6. The pattern of ocular involvement in 17 patients
Terminal ileum 9
Cecum 5
Ascending colon 2
Transverse colon 2
Esophagus 2
Site  No. of patients
Table 7. The sites of gastrointestinal ulcerations in 11 patients
Oral ulcers as initial  86.3 NA NA 78.5 86.5 66.0  64.0 
symptom (%)
Male/female ratio 0.52 0.57 0.61 0.63 1.03 1.5 1.9
Mean age at onset (yr) 35.2 33.0  NA 20S 25.6 25.0  NA
Oral ulcers (%) 100 98.8 100 97.5 100 99 100
Genital ulcers (%) 75.3 83.2 71.1 56.7 88.2 74.5 78.0 
*EN-like lesions (%) 52.1
84.3**
68.1 55.3 47.6 37.0 NC
� PPL/ 57.5 29.7 NC 54.2 50.8 NC
pseudofolliculitis (%)
Positive pathergy (%) 34.2 15.4 47.3 NA 56.8 51.8 30.0 
Arthritis (%) 24.7 38.4 NC 24.2  6.7 59 48
Ocular lesions (%) 23.3 50.9 30.7 28.5 28.9 58.9 75.0 
GI lesions (%) 15.1 7.3 5.3 4.0  2.8 15.8 3.0 
Vascular lesions (%) 5.5 1.8 10.5 NA 16.8 25.1 8.0 
CNS lesions (%) 4.1 4.6 3.5 5.7 2.2 12.8 20.0 
Epididymitis (%) 1.4 0.6 1.8 NA NA 15.9 17.0 
1, the current study; 2, Bang et al. (multicenter study) (13); 3, Eun et al.
(14); 4, Bang et al. (15); 5, Gurler et al. (Turkish study) (16); 6, Zouboulis
et al. (German study) (17); 7, Kaklamanis et al. (Greece study) (3). NA,
not available; NC, not clearly described; *EN, erythema nodosum; **,
described as skin lesions; 
� PPL, papulopustular lesions.
Clinical features   1   2  3   4  5   6   7  
Table 9. The clinical features of Behc ,et’s disease in Korea,
Turkey, Germany, and Greece
Male 11 (44.0) 14 (56.0)
Female 14 (29.2) 34 (70.8)
No. of patients with positive
pathergy reaction (%)
No. of patients with negative
pathergy reaction (%)
Table 8. The results of pathergy reaction in 25 patients
. .ours was lower than that in other countries. However, the
overall features of clinical manifestations were similar to those
in the literature (3).
Although most clinical manifestations in the present study
were in line with other Korean studies, some clinical features
were somewhat different. Eun et al. described the highest rate
of a positive pathergy reaction (14), and this might be related
with the needle used in the pre-AIDS-era. After the introduc-
tion of a disposable needle, the prevalence and intensity of a
positive pathergy reaction have been described to decrease
when compared with those by the non-disposable needle used
in the pre-AIDS era (20). The current study showed a some-
what higher rate of a positive pathergy reaction than the mul-
ticenter study in Korea (13). We previously reported that the
positive pathergy reaction was usually found in the active phase
of the disease in individual cases with a positive reaction (6).
In the current study, the pathergy reaction was also done in
the relatively active stage of BD during the follow-up, and
this might be one reason for the somewhat higher rate of the
positive pathergy reaction. On the other hand, the information
about the relationship between the pathergy reaction and
gender of patients with BD has been limited. Yazici et al.
described that even though the prevalence of the pathergy
reaction was not different according to gender, male patients
had a stronger reaction (21). However, the positive pathergy
reaction was more commonly encountered in male patients in
the current study and in the multicenter study in Korea (13),
although there was no statistical significance in our study. In
addition, because the strong reaction such as a pustule forma-
tion was very rare as demonstrated in our previous report (6),
the difference of the intensity of this reaction between male
and female patients could not be assessed.
The uveitis of BD involves both anterior and posterior uveal
tracts and causes the loss of sight in 25% of patients (3, 22). In
the present study, the most common pattern of ocular lesions
was the involvement of both the anterior and posterior tracts.
We used a therapeutic regimen, which consisted of cyclo-
sporine (5 mg/kg/day) for first 6 months, followed by azathio-
prine (1-2 mg/kg/day) for 18 months. Prednisolone (PD) (1
mg/kg/day) was initially given and was tapered to 5 mg/day
within one month. Colchicine (1.2 mg/day) was prescribed
together. Topical mydriatic agents and corticosteroids drops
were given without systemic immunosuppressive agents for
patients with only anterior uveitis. Because the initial beneficial
effect of cyclosporine may become dampened with continued
use for 6 months (23), azathioprine was prescribed after the
induction of remission with cyclosporine. There was no patient
with the visual loss due to the ocular lesions by BD during
the follow-up, and those regimens seem to be effective for the
treatment of Behc ,et’s  uveitis. On the other hand, the preva-
lence of ocular lesions in the multicenter study in Korea (13)
was much higher than those in the previous studies in Korea
and in the current study, and this might be partly due to the
use of the Japanese criteria that has emphasized the presence
of ocular involvement.
Although the common sites of gastrointestinal ulcerations
in the present study were not different from those in the liter-
ature (2, 3), the frequency of these manifestations was much
higher than that of other studies in Korea (Table 9). The fre-
quency of gastrointestinal ulcerations in BD has shown lots
of geographical variation: prevalent in Japan, while rarely
described in Turkey (24, 25). On the other hand, the manage-
ment of the intestinal BD is usually done in accordance with
that of inflammatory bowel disease (2, 3). In the current study,
sulfasalazine (2-3 g/day) and PD (0.5 mg/kg/day) were initially
given for patients with an active intestinal ulceration or patients
undergone the surgical procedures due to the bleeding or
perforation from the intestinal ulceration. PD was tapered to
5 mg/day within one month. Colchicine (1.2 mg/day) was also
prescribed. Cyclophosphamide (1-2 mg/kg/day) was given
together to patients with an active vasculitis for 3 to 6 months.
The ulcerative lesions of the intestinal BD are diverse from
small shallow ulcerations to large and deep penetrating ulcera-
tions liable to perforate. Moreover, postoperative recurrence and
complications are relatively frequent (26, 27). In the present
study, no patients with intestinal BD received the surgical
treatment due to the complications of intestinal ulcerations
during the follow-up. So, our therapeutic regimens appeared
to be effective for patients with the active intestinal ulcerations
or patients undergone the surgery due to the complicated
ulcerations. Some patients with ileocecal ulcerations could be
misdiagnosed as appendicitis because of their location. Lee
et al. reported 6 patients (23.1%) who were misdiagnosed as
appendicitis before operation (26). We experienced 3 such
patients (27.3%).
Yurdakul et al. described that the attacks of arthritis in BD
were mostly monoarticular (68%), and knees, ankles, and wrists
were the most commonly involved joints (28). Our study
revealed very similar results. The prevalence of inflammatory
arthritis in our study was comparable to those of other Korean
studies. However, Kim et al. described that the frequency of
arthropathy was 70.2% and the most common pattern of
involvement was oligoarticular (29). Such a high frequency of
the joint involvement might be speculated because they used
the questionnaire to obtain the information of joint symptoms,
and also employed a broad concept “arthropathy” rather than
the inflammatory arthritis. 
The HLA-B51 antigen has been a well-known genetic factor
associated with BD, and has appeared to be higher in countries
adjacent to the ancient Silk Road (1). Lee et al. described that
the frequency of HLA-B5 in patients with BD was 44.2% in
1988 (30). The odd ratio for the development of BD in Korean
with HLA-B51 in another Korean study was 6.8 (95% con-
fidence interval; 3.0-15.3), and patients with this antigen
tended to manifest uveitis, erythema nodosum, and the full-
blown syndrome as complete BD (8). HLA-B51 in the present
study was positive in 50.7% of BD patients. On the other
hand, familial BD was described in 13.4% of patients with
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was documented in 8 patients (11%) in the current study. In
addition, the occurrence of BD in a family of which 4 siblings
were affected could not be explained by any specific HLA
phenotype (32). Nishiura et al. reported that the prevalence
of HLA-B51 in patients with a familial BD was 92% (33).
It was 87.5% in the present study. Therefore, the HLA-B51
antigen was more commonly found in patients with a familial
BD than in patients without a family history of BD.
This is the first clinical study of BD in a confined area of
Korea. Some clinical features have been well known to be
different according to the ethnic areas, and regional differences
within a country have also been reported. We hope that the
clinical feature of BD in other areas of this country will be
reported and the criteria for the clinical studies of BD will be
unified to easily compare to each other. 
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